...
首页> 外文期刊>Dermatologic surgery >Transcatheter duplex ultrasound-guided sclerotherapy for treatment of greater saphenous vein reflux: preliminary report.
【24h】

Transcatheter duplex ultrasound-guided sclerotherapy for treatment of greater saphenous vein reflux: preliminary report.

机译:经导管双工超声引导下的硬化疗法治疗大隐静脉返流:初步报告。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Surgical ligation and stripping of the greater saphenous vein has been the gold standard for treatment of saphenofemoral junction incompetence for several years. Although sclerotherapy of the greater saphenous vein has also been advocated by some phlebologists, the procedure can be technically challenging and has resulted in inadvertent nontarget injection. OBJECTIVE: The purpose of this study was to assess the effectiveness and safety of transcatheter duplex-guided sclerotherapy for the treatment of varicose veins due to saphenofemoral junction reflux. METHODS: Fifty-one greater saphenous veins in 50 patients were treated with transcatheter sclerotherapy. Using local anesthesia and ultrasound guidance, the greater saphenous vein was entered 15-45 cm below the saphenofemoral junction. An infusion catheter was placed over a guidewire and positioned under ultrasound guidance, and 3% sodium tetradecyl sulfate was administered below the saphenofemoral junction and along the course of an "empty" greater saphenous vein via the catheter. RESULTS: Catheter placement and treatment was possible in all patients, with 2-5 ml of 3% sodium tetradecyl sulfate administered per session. At the 24-hour and 1-week follow-ups, all treated greater saphenous vein segments were closed following initial treatment, with no flow detectable by continuous wave or color Doppler interrogation. No patients required re-treatment, with all veins remaining closed at 2- to 12-months follow-up. There have been no adverse reactions. CONCLUSION: Transcatheter duplex ultrasound-guided sclerotherapy should improve both the safety and efficacy of treatment compared to conventional ultrasound-guided sclerotherapy and offers an alternative to surgical ligation and stripping for those patients wishing to avoid surgery.
机译:背景:多年来,大结节隐静脉的外科手术结扎和剥脱术一直是治疗隐of股关节功能不全的金标准。尽管一些静脉生物学家也提倡大隐静脉的硬化疗法,但该手术在技术上可能具有挑战性,并导致了无意的非目标注射。目的:本研究旨在评估经导管双联引导的硬化疗法治疗therapy股交界处返流引起的静脉曲张的有效性和安全性。方法:对50例大隐隐静脉行经导管硬化治疗。使用局部麻醉和超声引导,大隐静脉在隐股交界处下方15-45 cm处进入。将输液导管放置在导丝上并置于超声引导下,并通过该导管在隐股线交界处并沿“空”大隐静脉给药3%的十四烷基硫酸钠。结果:所有患者均可以置入导管并进行治疗,每次疗程使用2-5 ml 3%的十四烷基硫酸钠。在24小时和1周的随访中,所有接受治疗的大隐静脉段在初次治疗后均被关闭,连续波或彩色多普勒询问均未检测到血流。没有患者需要重新治疗,在2到12个月的随访中所有静脉保持闭合。没有不良反应。结论:与常规超声引导硬化疗法相比,经导管双刀超声引导硬化疗法应同时提高治疗的安全性和有效性,并为那些希望避免手术的患者提供了手术结扎和剥离的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号